NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 74 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $31,027,000 | -32.2% | 1,573,357 | 0.0% | 2.10% | -94.2% |
| Q1 2021 | $45,737,000 | -4.0% | 1,573,357 | 0.0% | 36.38% | -41.2% |
| Q4 2020 | $47,665,000 | +90.4% | 1,573,357 | 0.0% | 61.89% | +58.9% |
| Q3 2020 | $25,032,000 | -19.4% | 1,573,357 | 0.0% | 38.95% | +104.4% |
| Q2 2020 | $31,058,000 | +60.1% | 1,573,357 | 0.0% | 19.06% | +137.3% |
| Q1 2020 | $19,399,000 | -33.3% | 1,573,357 | 0.0% | 8.03% | +4.7% |
| Q4 2019 | $29,091,000 | +33.5% | 1,573,357 | 0.0% | 7.67% | +16.1% |
| Q3 2019 | $21,791,000 | -5.4% | 1,573,357 | 0.0% | 6.61% | -44.2% |
| Q2 2019 | $23,034,000 | – | 1,573,357 | – | 11.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|